Startups
Stimalia
Stimalia is a Belgian bioelectronic-medicine company developing an investigational percutaneous implant, TraumaTone, to modulate the stellate ganglion for post-traumatic stress disorder. Its platform also includes CalmTone Vet, a development programme for trauma-related behavioural conditions in companion animals. The company’s current site states that both programmes are investigational and not available for sale; published response rates for other stellate-ganglion interventions are not proven Stimalia clinical outcomes. The official founder directory names CEO Olivier Ménage, CTO Pascal Doguet and CCO Sylvain d’Amico. Belgian KBO enterprise1026.843.681 is an active private limited company founded August26,2025, currently based at Rue Louis de Geer6, Ottignies-Louvain-la-Neuve; its registry additionally names directors Stanton Rowe and George Severiades and records Olivier’s delegated directorship. IGNITY lists the company as a supported member. Incubator membership and partner logos do not establish cash investment, and no primary completed funding announcement or direct buyer ticket was verified. Current founder and statutory-board coverage comprises five people and eight distinct roles, not a claim to the private employee roster.
Founded 2025
Team
George SeveriadesDirector |
 Olivier MénageDelegated Director · Director · CEO and Co-Founder |
 Pascal DoguetDirector · CTO and Co-Founder |
Stanton RoweDirector |
 Sylvain d'AmicoCCO and Co-Founder |
Investments
No investment rounds on record yet.